Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Imaging biomarkers in neurodegeneration: current and future practices | Alzheimer's Research & Therapy | Full Text
Understanding neurodegeneration after traumatic brain injury: from mechanisms to clinical trials in dementia | Journal of Neurology, Neurosurgery & Psychiatry
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid* - Molecular & Cellular Proteomics
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias - The Lancet Neurology
Current state of Alzheimer's fluid biomarkers | SpringerLink
Frontiers | Re-thinking the Etiological Framework of Neurodegeneration | Neuroscience
Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma | Nature Communications
Benefits, pitfalls, and future design of population-based registers in neurodegenerative disease | Neurology
Neurodegenerative disease - Wikipedia
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases - Mayo Clinic Proceedings
Frontiers | Ophthalmic Biomarkers for Alzheimer's Disease: A Review | Aging Neuroscience
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders | Nature Reviews Neurology
Biomarkers for Alzheimer's disease: current status and prospects for the future - Blennow - 2018 - Journal of Internal Medicine - Wiley Online Library
Preclinical markers of neurodegenerative diseases | Download Table
RETISPEC AND TORONTO MEMORY PROGRAM AWARDED GRANT TO LAUNCH INNOVATIVE EARLY DETECTION PROGRAM FOR ALZHEIMER'S IN TORONTO, CANADA
A Primary Care Agenda for Brain Health: A Scientific Statement From the American Heart Association | Stroke
Association between circadian rhythms and neurodegenerative diseases - The Lancet Neurology
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment: Trends in Pharmacological Sciences
University College London/University of Gothenburg PhD course “Biomarkers in neurodegenerative diseases” 2019—course organisation | Alzheimer's Research & Therapy | Full Text
DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesis - Liss - 2021 - Journal of Internal Medicine - Wiley Online Library
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation - The Lancet Neurology
